Logo
Bg pattern

OSDY 20 micrograms/80 microliters Injectable Solution in Pre-filled Pen

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use OSDY 20 micrograms/80 microliters Injectable Solution in Pre-filled Pen

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Contents of the leaflet

  1. Introduction
  2. What is Osdy and what is it used for
  3. What you need to know before you start using Osdy
  4. How to Use Osdy
  5. Possible Side Effects
  6. Storage of Osdy
  7. Contents of the Pack and Further Information

Introduction

Package Leaflet: Information for the User

Osdy 20 micrograms/80 microliters solution for injection in pre-filled pen

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

Contents of the Package Leaflet

  1. What is Osdy and what is it used for
  2. What you need to know before you start using Osdy
  3. How to use Osdy
  4. Possible side effects
  5. Storage of Osdy
  6. Contents of the pack and further information

1. What is Osdy and what is it used for

This medicine contains the active substance teriparatide, which is used to increase bone strength and reduce the risk of fractures by stimulating bone formation.

Teriparatide is used for the treatment of osteoporosis in adults. Osteoporosis is a disease that makes your bones wear out and become fragile. This disease is especially common in women after menopause, but it can also occur in men. Osteoporosis is also common in patients treated with corticosteroids.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you start using Osdy

Your healthcare professional will teach you how to use the Osdy pen.

Do not use Osdy

  • if you are allergicto teriparatide or any of the other ingredients of this medicine (listed in section 6).
  • if you have high levels of calcium (pre-existing hypercalcemia).
  • if you have severe kidney problems.
  • if you have ever been diagnosed with bone cancer or other types of cancer that have spread (metastasized) to your bones.
  • if you have certain bone diseases. If you have a bone disease, consult your doctor.
  • if you have high levels of alkaline phosphatase in your blood without apparent explanation, which could indicate that you have Paget's disease of the bone (a disease with abnormal bone changes). If you are not sure, consult your doctor.
  • if you have received radiation therapy that may have affected your bones.
  • if you are pregnant or breastfeeding.

Warnings and Precautions

Teriparatide may cause an increase in the amount of calcium in your blood or urine.

Consult your doctor or pharmacist before starting or while using teriparatide:

  • if you constantly have nausea, vomiting, constipation, low energy, or muscle weakness. These may be symptoms of too much calcium in your blood.
  • if you have kidney stones or a history of kidney stones.
  • if you have kidney problems (moderate renal insufficiency).

Some patients, after the first doses, experience dizziness or an increased heart rate. For the first doses, use teriparatide in a place where you can sit or lie down immediately if you feel dizzy.

The recommended treatment time of 24 months should not be exceeded.

Teriparatide should not be used in adults who are still growing.

Children and Adolescents

Teriparatide should not be used in children and adolescents (under 18 years of age).

Other Medicines and Osdy

Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines, because occasionally interactions may occur (e.g., digoxin/digitalis, a medicine used to treat heart diseases).

Pregnancy and Breastfeeding

Do not use teriparatide if you are pregnant or breastfeeding. If you are a woman of childbearing age, you should use effective contraceptive methods during treatment with teriparatide. If you become pregnant, treatment with teriparatide should be discontinued. Consult your doctor or pharmacist before using any medicine.

Driving and Using Machines

Some patients may feel dizzy after the injection of teriparatide. If you feel dizzy, do not drive or use machines until you feel better.

Osdy Contains Sodium

This medicine contains less than 1 mmol of sodium (23 mg) per dose; it is essentially "sodium-free".

3. How to Use Osdy

Follow exactly the administration instructions of this medicine indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.

The recommended dose is 20 micrograms administered once a day by injection under the skin (subcutaneous injection) in the thigh or abdomen. To help you remember to inject your medicine, inject it at the same time every day.

Inject teriparatide every day for as long as your doctor prescribes it. The total duration of treatment with teriparatide should not exceed 24 months. You should not receive more than one 24-month treatment cycle with teriparatide in your lifetime.

Teriparatide can be injected at mealtime.

Consult the User Manual included in the package with instructions on how to use the Osdy pen.

No needles are included with the pen. The device can be used with 31G insulin pen needles.

The injection of teriparatide should be performed shortly after removing the pen from the refrigerator, as indicated in the User Manual. Return the pen to the refrigerator immediately after use. You should use a new needle for each injection and discard it after each use. Do not store the pen with the needle attached. Never share your teriparatide pen with others.

Your doctor may recommend that you take calcium and vitamin D with teriparatide. Your doctor will tell you how much to take each day.

Osdy can be used with or without food.

If You Use More Osdy Than You Should

If you have accidentally administered more teriparatide than prescribed, consult your doctor or pharmacist.

The effects that could be expected from an overdose include nausea, vomiting, dizziness, and headache.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.

If You Forget or Cannot Inject Osdy at the Usual Time, do it as soon as you can that same day. Do not administer a double dose to make up for forgotten doses. Do not inject more than once on the same day. Do not try to make up for the forgotten dose.

If You Stop Treatment with Osdy

If you are thinking of stopping treatment with teriparatide, please consult your doctor. Your doctor will advise and decide how long you should be treated with teriparatide.

If you have any other questions about the use of this medicine, ask your doctor or pharmacist.

4. Possible Side Effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The most common side effects are pain in the limbs (very common, may affect more than 1 in 10 patients), discomfort, headache, and dizziness (common). If you feel dizzy after an injection, sit or lie down until you feel better. If it does not improve, consult your doctor before continuing treatment. Cases of fainting associated with the use of teriparatide have been reported.

If you experience discomfort such as redness of the skin, pain, swelling, itching, bruising, or slight bleeding around the injection site (common), these should disappear within a few days or weeks. If not, tell your doctor as soon as possible.

Some patients may have experienced allergic reactions just after the injection, consisting of difficulty breathing, swelling of the face, skin rash, and chest pain (rare frequency). In rare cases, severe and potentially life-threatening allergic reactions, including anaphylaxis, may occur.

Other side effects are:

Common: may affect up to 1 in 10 patients

  • increase in blood cholesterol levels
  • depression
  • neuralgic pain in the leg
  • feeling of fainting
  • irregular palpitations
  • difficulty breathing
  • increased sweating
  • muscle cramps
  • loss of energy
  • fatigue
  • chest pain
  • low blood pressure
  • stomach acid (pain or burning sensation just below the sternum)
  • vomiting
  • hernia of the tube that carries food to the stomach
  • low hemoglobin or low red blood cell count (anemia)

Uncommon: may affect up to 1 in 100 patients

  • increased heart rate
  • abnormal heart sound
  • shortness of breath
  • hemorrhoids (piles)
  • accidental loss or leakage of urine
  • increased need to urinate
  • weight gain
  • kidney stones
  • pain in the muscles and joints. Some patients have experienced severe back cramps or pain and had to be hospitalized.
  • increase in blood calcium levels
  • increase in blood uric acid levels
  • increase in levels of an enzyme called alkaline phosphatase.

Rare: may affect up to 1 in 1,000 patients

  • reduction of kidney function, including renal failure
  • swelling, mainly in the hands, feet, and legs.

Reporting of Side Effects

If you experience any side effects, talk to your doctor, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines Monitoring System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Osdy

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and pen after EXP. The expiry date is the last day of the month stated.

Teriparatide should always be stored in a refrigerator (between 2°C and 8°C). You can use teriparatide for 28 days after performing the first injection while the pen is stored in a refrigerator (between 2°C and 8°C).

Do not freeze teriparatide. Avoid placing the pens near the freezer compartment of the refrigerator to prevent freezing. Do not use teriparatide if it has been frozen.

Each pen should be discarded after 28 days, even if it is not completely empty.

Teriparatide contains a clear and colorless solution. Do not use teriparatide if it has solid particles or if the solution is cloudy or discolored.

Medicines should not be disposed of via wastewater or household waste. Place the packaging and any unused medicines in the SIGRE collection point at the pharmacy. Ask your pharmacist how to dispose of the packaging and any unused medicines. This will help protect the environment.

6. Contents of the Pack and Further Information

  • Composition of Osdy
  • The active substance is teriparatide. Each milliliter of solution for injection contains 250 micrograms of teriparatide.
  • The other ingredients are glacial acetic acid, sodium acetate, mannitol, metacresol, and water for injections. Additionally, a solution of hydrochloric acid and/or sodium hydroxide may have been added to adjust the pH.

Appearance of the Product and Contents of the Pack

Osdy is a clear and colorless solution. It is presented in a cartridge included in a pre-filled disposable pen. Each pen contains 2.4 ml of solution sufficient for 28 doses. The pens are available in packs containing one or three pens. Not all pack sizes may be marketed.

Marketing Authorization Holder

Reddy Pharma Iberia, S.A.

Avda. Josep Tarradellas nº 38

08029 Barcelona

Spain

Manufacturer

betapharm Arzneimittel GmbH,

Kobelweg 95,

86156 Augsburg

Germany

or

Pharmadox Healthcare Ltd.,

KW20A Kordin Industrial Park

Paola PLA 3000

Malta

or

Rual Laboratories SRL

313, Splaiul Unirii, Building H

1st floor, sector 3

030138 Bucuresti

Romania

or

Dr. Reddy's Laboratories Romania S.R.L.

Space 1 Sector 1 30-32 Strada Daniel Danielopolu 5th Floor,

Bucharest, 014134

Romania

This medicine is authorized in the Member States of the European Economic Area under the following names:

Country

Name

Germany

Teriparatid beta 20 Mikrogramm/80 Mikroliter Injektionslösung im Fertigpen

Spain

Osdy 20 microgramos/80 microlitros solución inyectable en pluma precargada EFG

Date of the Last Revision of this Leaflet:May 2025

Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

USER MANUAL FOR THE PEN

Osdy 20micrograms (μg)/ 80 microliters injectable solution in a pre-filled pen

teriparatide

Instructions for Use

Before using your new pen, please read the entireInstructions for Usesection. Carefully follow the instructions when using the pen.

Also, readthe leaflet included in the packaging.

Do not share your pen or needles as it may pose a risk of infection transmission.

Your pen contains medication for 28 days.

Osdy injection device with white cylinder, purple body, and red bands, showing parts such as button, cartridge, and gray cap

Always wash your hands before each injection. Prepare the injection site as your doctor or pharmacist has indicated.

  1. Remove the gray cap.

Hands holding an auto-injector with a transparent window showing the liquid level insideHands holding an auto-injector with a visible needle and a black arrow indicating the direction of application

  1. Place the needle

Remove the paper tab.Hands holding a medical device with a pointed end and a transparent cylinder

Place the needle by pressing it directlyonto the medication cartridge

Hand holding an auto-injector with the needle pointing towards the skin, black arrow indicating the direction of injection

Screw the needle until it is perfectly fixed.

Hands holding an auto-injector with a red arrow indicating the rotation movement of the device

Remove the outer needle cap and keep it.

Hand holding a syringe with a needle, a blue circle highlighting the base of the needle just before insertion into the skin

  1. Dose adjustment

Pullthe black injection button until it stops.

If you cannot pull the black injection button, see the Troubleshooting, Problem Esection on the back.

Hand holding a purple auto-injector pressing against the thigh with a black arrow indicating the direction of injection

Make sureyou see the red band.

Hand holding a syringe with a red band at the base and a needle marked with a blue circle

Removethe inner needle protector and discard it.

Hand holding a syringe with the needle inserted, blue circle highlighting the inner needle protector and the injection point

  1. Clean the administration area with an alcohol swab and inject the dose.

Hand holding a purple auto-injector inserting the needle into the thigh skin with an arrow indicating the direction

Pinch your thigh or abdomen skin gently and insert the needle directly under your skin.

Hand holding a purple auto-injector inserting the needle into the abdomen skin with an arrow indicating the direction

Pressthe black injection button until it stops. Keep it pressed and count slowly to 5. Then, remove the needle from the skin.

  1. Confirm the dose

IMPORTANT

After completing the injection: Once the needle is removed from the skin, make surethe black injection button has been inserted all the way. If the white cylinder is not visible, you have completed the injection steps correctly.

Hand holding a pre-filled purple injection device highlighted with a blue circle

DO NOTsee any part of the white cylinder. If you have already injected and see it, do not inject a second time on the same day. Instead, YOU MUST readjust the Osdy pen(see Troubleshooting, Problem Asection).

Hand holding a purple vial with a black cap crossed out by a red circle with a diagonal red line

  1. Remove the needle

Hand holding a purple auto-injector with the needle exposed and pointing downwards, close-up of the needle

Place the outer needle cap.

Hands holding an auto-injector with an orange needle visible inserted into the skin

Completely unscrew the needle by giving the outer needle cap 3 to 5 full turns. Remove the needle and discard it as your doctor or pharmacist has indicated.

Hand holding an auto-injector with the tip pointing towards the skin and an arrow indicating the direction of injection

Remove the needle and discard it as your doctor or pharmacist has indicated.

Hands holding an auto-injector with a visible needle protector and an arrow indicating the direction of insertion

Put the gray cap back on. Store the Osdy pen in the refrigerator immediately after use.

The instructions for handling needles do not intend to replace local, institutional, or healthcare professional guidelines.

To obtain more information or if you have any questions, consult the back of this page.

Troubleshooting

PROBLEM

SOLUTION

  1. The white cylinder is still visible after pressing the black injection button. How do I readjust my pen?

Hand holding a purple vial with a black cap crossed out by a red circle with a diagonal line

Follow these steps to readjust the pen:

  1. If you have already injected, DO NOT inject a second time on the same day.
  2. Remove the needle.
  3. Attach a new needle, remove the outer needle cap, and keep it.
  4. Pull the black injection button until it stops. Make sure you see the red band.
  5. Remove the inner needle protector and discard it.
  6. Point the needle downwards into an empty container. Press the black injection button until it stops. Keep it pressed and count slowly to 5. You may see a small jet or drop of fluid. When finished, the black injection button should be inserted all the way.
  7. If you still see the white cylinder, please contact your doctor or pharmacist.
  8. Place the outer needle cap on the needle. Completely unscrew the needle by giving the outer needle cap 3 to 5 full turns. Remove the needle and discard it as your doctor or pharmacist has indicated. Put the gray cap back on and store the Osdy pen in the refrigerator.

You can avoid this problem by always using a NEW needle for each injection and pressing the black injection button all the way while counting slowly to 5.

  1. How can I know if my pen is working?

The pen is designed to inject a complete dose each time it is used, following the instructions in the Instructions for Usesection. The black injection button should be inserted all the way to confirm that the pen has injected the complete dose.

Remember to use a new needle for each injection to ensure your pen works correctly.

  1. I see an air bubble in my pen.

A small air bubble will not affect your dose or harm you. You can proceed with the administration of your dose as usual.

  1. I cannot remove the needle.

  1. Place the outer needle cap on the needle.
  2. Use the outer needle cap to unscrew the needle.
  3. Completely unscrew the needle by giving the outer needle cap 3 to 5 full turns.
  4. If you still cannot remove the needle, ask someone for help.
  1. What should I do if I cannot pull the black injection button?

Switch to a new pen to administer your dose as indicated by your doctor or pharmacist.

This means you have already used all the medication that could be injected accurately, even if you can see that some medication is still left in the cartridge.

Cleaning and Storage

Cleaning your pen

  • Clean the outside of your pen with a damp cloth.
  • Do not submerge your pen in water, or wash or clean it with any liquid.

Storing yourpen

  • Store your pen in the refrigerator immediately after each use. Read and follow the instructions for storing your pen in the Patient Information Leaflet.
  • Do not store your pen with the needle attached, as this may cause air bubbles to form in the cartridge.
  • Store the pen with the gray cap on.
  • Never store the pen in the freezer.
  • If the medication has been frozen, discard the device and use a new pen.
  • If the pen has been left out of the refrigerator, do not discard it. Return it to the refrigerator and contact your doctor or pharmacist.

Disposal of Needles and Pen

Disposal of Needles and Pen

  • Before disposing of the Osdy pen, make sure you have removed the needle from the pen.
  • Place used needles in a puncture-proof container or a hard plastic container with a secure lid. Do not throw needles directly into the household trash.
  • Do not recycle the filled puncture-proof container.
  • Consult your healthcare professional about the available options for properly disposing of the pen and the puncture-proof container.
  • The instructions for handling needles do not intend to replace local, institutional, or healthcare professional guidelines.
  • Discard your pen 28 days after the first use.

Other Points of Interest

  • The Osdy pen contains medication for 28 days.
  • Do not transfer the medication to a syringe.
  • Write down the date of your first injection on a calendar.
  • Read and follow the instructions in the Patient Information Leafleton how to use the medication.
  • Check the pen label to ensure you have the correct medication and that it has not expired.
  • Contact your doctor or pharmacist if you have observed any of the following:
  • The pen appears to be damaged
  • The solution is NOT transparent and colorless and particle-free
  • Use a new needle for each injection.
  • During injection, you may hear one or more clicks, which is the normal operation of the device.
  • It is not recommended that blind or visually impaired individuals use the pen without the help of a trained person in the proper use of the device.

Manufactured by:

betapharm Arzneimittel GmbH,

Kobelweg 95,

86156 Augsburg

Germany

or

Pharmadox Healthcare Ltd.,

KW20A Kordin Industrial Park

Paola PLA 3000

Malta

or

Rual Laboratories SRL

313, Splaiul Unirii, Building H

1st floor, sector 3

030138 Bucuresti

Romania

or

Dr. Reddy's Laboratories Romania S.R.L.

Space 1 Sector 1 30-32 Strada Daniel Danielopolu 5th Floor,

Bucharest, 014134

Romania

This user manual was revised in May 2024

Online doctors for OSDY 20 micrograms/80 microliters Injectable Solution in Pre-filled Pen

Discuss questions about OSDY 20 micrograms/80 microliters Injectable Solution in Pre-filled Pen, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80
5.0 (9)
Doctor

Iryna Reznychenko

Gynecology 26 years exp.

Dr Iryna Reznychenko is an obstetrician-gynaecologist, paediatric gynaecologist, and certified lactation consultant. She provides online consultations for women at all stages of life – from adolescence to menopause. Her work combines medical care for gynaecological conditions with dedicated support for breastfeeding challenges, both physical and emotional.

Areas of expertise:

  • interpretation of test results and personalised treatment planning
  • menstrual irregularities, PCOS, endometriosis
  • abnormal uterine bleeding, endometrial hyperplasia, cervical dysplasia
  • care during perimenopause and menopause, hormonal balance, cancer prevention
  • breastfeeding issues: nipple pain, cracked skin, blocked ducts, low milk supply
  • support during the postpartum and lactation period
Dr Reznychenko offers a clear, attentive and professional approach. Her consultations help prevent minor discomforts from developing into more serious concerns – all in a convenient online format.
Camera Book a video appointment
€55
5.0 (11)
Doctor

Mar Tabeshadze

Endocrinology 11 years exp.

Dr. Mar Tabeshadze is a licensed endocrinologist and general practitioner in Spain. She provides online consultations for adults, offering medical support for a wide range of endocrine conditions and related health concerns.

  • Diagnostic consultations for suspected endocrine disorders
  • Management of thyroid conditions, including in pregnant women
  • Early detection and treatment of type 1 and type 2 diabetes, with personalised therapy plans
  • Obesity treatment: identifying underlying causes of weight gain, combining medication and non-pharmacological strategies, and long-term support
  • Diagnosis and treatment of endocrine-related skin, hair, and nail issues
  • Ongoing care for patients with osteoporosis, pituitary, and adrenal gland disorders
Dr. Tabeshadze takes a patient-centred approach based on evidence-based medicine. Her goal is to help patients achieve hormonal balance, manage chronic conditions effectively, and improve overall well-being through targeted, personalised care.
Camera Book a video appointment
€55
5.0 (29)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
Camera Book a video appointment
€60
5.0 (29)
Doctor

Dmytro Horobets

Family medicine 7 years exp.

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

  • Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
  • Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
  • Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
  • Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
  • General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
  • Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
  • Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
  • Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.
Camera Book a video appointment
€60
0.0 (2)
Doctor

Marianna Neshta

Endocrinology 25 years exp.

Marianna Neshta is a medical doctor specialising in endocrinology and ultrasound diagnostics. She provides online consultations for adults, focusing on the diagnosis, treatment, and long-term management of endocrine disorders. Her approach includes personalised care plans, analysis of lab results and ultrasound scans, and evidence-based treatment.

Key areas of expertise:

  • Type 1 and Type 2 diabetes – diagnosis, therapy adjustment, CGM interpretation, and prevention of chronic complications
  • Obesity – treatment using both medication and lifestyle strategies, including modern GLP-1 medications and tailored follow-up plans
  • Thyroid disorders – ultrasound assessment, treatment planning, and management during pregnancy
  • Male hypogonadism – age-related or hormonal, including diagnostics and therapy
  • Metabolic syndrome, prediabetes, lipid disorders – risk assessment, lifestyle recommendations, and medical treatment
  • Calcium metabolism disorders – diagnosis and management of osteoporosis, hyperparathyroidism, and hypoparathyroidism
Dr Neshta applies current clinical guidelines and diagnostic tools, offering medical support adapted to each patient’s individual needs — all in an accessible online format.
Camera Book a video appointment
€45

Frequently Asked Questions

Is a prescription required for OSDY 20 micrograms/80 microliters Injectable Solution in Pre-filled Pen?
OSDY 20 micrograms/80 microliters Injectable Solution in Pre-filled Pen requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in OSDY 20 micrograms/80 microliters Injectable Solution in Pre-filled Pen?
The active ingredient in OSDY 20 micrograms/80 microliters Injectable Solution in Pre-filled Pen is teriparatide. This information helps identify medicines with the same composition but different brand names.
Who manufactures OSDY 20 micrograms/80 microliters Injectable Solution in Pre-filled Pen?
OSDY 20 micrograms/80 microliters Injectable Solution in Pre-filled Pen is manufactured by Reddy Pharma Iberia S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of OSDY 20 micrograms/80 microliters Injectable Solution in Pre-filled Pen online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether OSDY 20 micrograms/80 microliters Injectable Solution in Pre-filled Pen is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to OSDY 20 micrograms/80 microliters Injectable Solution in Pre-filled Pen?
Other medicines with the same active substance (teriparatide) include DURATIL 20 micrograms/80 microliters Injectable Solution in Pre-filled Pen, FORSTEO 20 micrograms/80 microliters, injectable solution, LIVOGIVA 20 micrograms/80 microliters Injectable Solution in Pre-filled Pen. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.
Follow us on social media